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previous severe reaction to contrast medium)3 and a low-
osmolar medium was reasonably available.
In regard to both the issue of wrongfulness and negligence
our courts will undoubtedly be influenced by what is considered
'common practice' and 'accepted practice' within a medical
specialty,12 and that may be co-determined by socio-economic
considerations.
On the issue of informed consent, there is no indication that
our courts will abandon their standpoint that the quantum of
information to be supplied by the doctor to the patient is that
which a reasonable doctor will give,13 in favour of the current
. American judicial view that the standard is that of what the
reasonable patient will require. 14 The English courts have also
opted for the former, more 'conservative' view. ls According to
our law a patient must be informed of probable side-effects of
a medical procedurel6 but need not be apprised of highly
uncommon or very unusual side-effects. 13 .
It would appear, therefore, that from a strictly legal point of
view a radiologist need not inform the patient of the availability
of a low-osmolar substance with its slightly lower risk of
adverse side-effects. On the other hand, where a low-osmolar
substance is in fact available in a particular practice and is
economically within the means of the patient, it would certainly
be reasonable for the doctor to apprise the patient of the
position, and either to suggest the use of the safer substance or
to leave the choice to the patient. But where, in a public
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hospital, the low-osmolar substance is not economically avail-
able for general use, there would obviously be no reason for
the radiologist to canvass the issue at all when consulting with
the patient.
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Blood oxygen saturation levels during
conscious sedation with midazolam
A report of 16 cases
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Summary
In a-double-blind randomized sbJdy on 16 healthy
individualS, two groups of subjects (8 in each group)
received either midazoIam (Dormicum; Roche) 0,1
mgJkg oc placebo intravenously for conscious seda-
tion during oral surgical procedures.. Oxygen satura-
tion of the blood was measured at different stages.
Ten minutes after administration of the drug, the
percentage oxygen saturation was significantly lower
. (P < 0,05) in the midazolam group than in the placebo
group.
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In spite of the remarkable efficacy of local anaesthetics and
advances in techniques which make oral surgical procedures
acceptable and often painless, the fear of pain and discomfort
is a common problem among dental patients. For certain
apprehensive patients whose fears cannot be adequately allayed,
general anaesthesia may be used, but because of the potential
hazards associated with this procedure it is not always
considered to be a feasible alternative.
Intravenous administration of sedatives and narcotic agents,
a practice referred to as conscious sedation, has been success-
fully used in conjunction with local anaesthesia for relief of
anxiety, sedation, reduction of spontaneous movements, and
amnesia. In contrast with general anaesthesia, verbal communi-
cation with the patient is possible throughout the procedure.
The results of conscious sedation studies l for cardiac
catheterization, urological procedures, bronchoscopy and gastro-
scopy have shown that intravenous midazolam (Dormicum;
Roche), a 1,4-benzodiazepine, also has the useful sedative and
amnesic effects found with other benzodiazepines. Since several
studiesH have reported anaesthetic-associated deaths occurring
in the dental chair, probably as a result of hypoxia, it was
decided to investigate the effect of midazolam on blood oxygen
saturation levels in patients receiving this drug for minor oral
surgical procedures.
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TABLE I. MEANS, RANGES AND PVALUES OF BLOOD OXYGEN SATURATION LEVELS
Midazolam (N = 8) Placebo (N = 8)
Stage
Pre-drug
10 min post-drug
Post-block
15 min
30 min
45min
Mean (%)
Jl9,750
96,125
97,125
97,875
97,375
97,500
Range (%)
100,00 - 99,00
99,00 - 92,00
99,00 - 94,00
100,00 • 95,00
99,00 - 95,00
99,00 - 95,00
Mean (%) Range (%)
98,875 100,00·97,00
99,250 100,00 - 98,00
98,000 100,00 - 97,00
97,125 100,00 - 94,00
96,625 100,00 - 95,00
97,571 100,00 - 95,00
Pvalue
0,0796
0,0038
0,2945
0,4479
0,1426
0,8581
Subjects and methods Discussion
In this double-blind randomized study, 16 healthy individuals
were divided into two groups and received either midazolam or
saline, as placebo, intravenously. No premedication was given on
the morrting of surgery and the patients were treated as outpatients.
All the procedures were carried out with patients in the supine
position in a reclining dental chair. An indwelling 2I-gauge l:iuner-
fly needle was inserted into a vein on the dorsum of the hand. The
intravenous dose of midazolam was given slowly over 15 seconds
and limited to 0,1 mglkg body weight since the objective was to
obtain a sedated but still co-operative patient. Ten minutes after
injection of the drug, the appropriate dental block was performed
using a vasoconstrictor-free local anaesthetic. Verbal contact was
maintained with patients throughout the procedure. Blood pressure,
heart rate, respiratory rate, ECG and oxygen saturation values
were recorded prior to injection and at various times throughout
the study period. Systolic, diastolic and mean blood pressures
were measured with a calibrated Critikon Dinamap adult/paediatric
vital signs monitor. For information on the arterial oxygen satura-
tion, a calibrated Ohmeda Biox In pulse oximeter was used, the
sensor of which was placed on a finger. Oxygen saturation values
were determined pre-operatively, 10 minutes after administration
of the drug, 5 minutes after the local anaesthetic injection and
every 15 minutes during the procedure (Fig. 1). Prilocaine 3%
with octapressin was used in all cases for local anaesthesia.
Results
Table I shows the means, ranges and p'values of blood oxygen
saturation levels at various stages of the procedure for all subjects.
Ten minutes after drug administration, the percentage oxygen
saturation was significantly lower (P < 0,05) in the midazolam
group than in the placebo group, as can also be seen in Fig. l.
This difference, however, had disappeared by the time further
readings were taken.
•••• •Midazolam
-Placebo
Midazolam was introduced in 1976 for clinical trials in the
USA. The drug exhibited properties common to other benzo-
diazepines, including anxiolytic, hypnotic, amnesic, muscle
relaxant and anticonvulsant properties, but it also has several
unique features. It is water-soluble at a pH below 4, highly
fat-soluble at body pH, and possesses a short beta elimination
phase of 1Y2 - 2 hours. 5 By virtue of its physiochemical
properties and its rapid biotransformation, midazolam is an
important addition to the existing drug armamentarium in
certain areas of anaesthesia. It can be used as a premedicant, a
sedative, and an induction agent, as well as a hypnotic.
Midazolam appears to be a safe and useful drug for the
induction of anaesthesia in patients with normal or diseased
cardiovascular systems because of its minimal haemodynamic
effects and benzodiazepine properties. 6 Intravenous induction
doses of midazolam can depress respiration, commonly causing
temporary apnoea (lasting about 30 seconds) with an incidence
in the adult population of patients of 18 - 78%.1 High intra-
venous doses of either midazolam or diazepam cause the same
degree of reduction in ventilation reaction and in carbon
dioxide pressure. This is induced by the respiratory muscula-
ture, hence it can be concluded that these compounds exercise
a direct but transient depressant effect on the respiratory
centre, which can be intensified by simultaneous administration
of opioid analgesics.8 .
While intravenously administered rnidazolam (0,1 mglkg)
appears to be a useful therapeutic adjunct to the management
of anxious patients during difficult oral surgical procedures
under local anaesthesia,9 the present study shows that signifi-
cant lowering of blood oxygen saturation levels may occur at
these doses. Although this lowering was not severe and did not
persist long enough to cause hypoxia, patients must be carefully
observed and dosage regimens strictly adhered to when
rnidazolam is used for conscious sedation procedures.
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STAGE OF PROCEDURE
PRE-ORUG 10 MIN. POST 15 MINUTES 30 MINUTES 45 MINUTES
POST DRUG BLOCK
Fig. 1. Mean oxygen saturation levels at various stages of the
procedure for patients receiving midazolam and placebo.
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